相关实验视频
Updated: Jun 5, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.2K
m6A甲基化修饰:抑制骨髓瘤转移的潜在途径
Tianrui Hu1, Guowei Wang1, Dong Wang1
1Department of Spine Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
International immunopharmacology
|December 11, 2024
概括
N-甲基化 (m6A) 修改影响骨髓瘤转移. 了解m6A的"写者"",抹消者"和"读者"相互作用,可以确定这种侵袭性骨癌的生物标志物和治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 骨髓瘤是一种具有高转移率的侵袭性骨癌,导致患者预后不佳.
- 骨髓瘤转移是治疗失败的主要原因.
- N-甲基化 (m6A) 修饰越来越多地被认为是其在骨髓瘤进展中的作用.
研究的目的:
- 审查m6A甲基化修饰在骨髓瘤转移中的作用.
- 阐明m6A调节器 (写字器,擦拭器,阅读器) 与转移相关因素之间的相互作用.
- 为了确定潜在的诊断生物标志物和治疗瘤转移的治疗点.
主要方法:
- 文献综述侧重于骨髓瘤中的m6A甲基化.
- 分析m6A成分与瘤转移途径之间的相互作用.
- 综合目前关于m6A修饰对骨髓瘤入侵和转移的影响的研究.
主要成果:
- m6A修饰通过各种信号通路显著影响骨髓瘤的侵袭和转移.
- 在转移过程中,m6A甲基化的特定"写入器"",删除器"和"读取器"都涉及到转移过程.
- 了解这些相互作用,可以了解驱动骨髓瘤传播的机制.
结论:
- 澄清m6A甲基化在骨髓瘤转移中的作用对于改善患者的治疗结果至关重要.
- m6A调节剂代表了对抗骨髓瘤转移的新型治疗策略的有希望的目标.
- 对m6A修饰的进一步研究可能会导致发现有价值的临床生物标志物.
更多相关视频
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

